NM_014141.6:c.98-227959C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.98-227959C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 151,712 control chromosomes in the GnomAD database, including 12,410 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 12410 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0950

Publications

2 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.98-227959C>T intron_variant Intron 1 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.98-227959C>T intron_variant Intron 1 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.98-227959C>T intron_variant Intron 1 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000625365.2 linkc.98-227959C>T intron_variant Intron 2 of 3 5 ENSP00000485955.1 A0A0D9SES4
CNTNAP2ENST00000637150.1 linkn.27-227959C>T intron_variant Intron 1 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.379
AC:
57512
AN:
151594
Hom.:
12407
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.182
Gnomad AMI
AF:
0.549
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.499
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.481
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.382
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.378
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.379
AC:
57526
AN:
151712
Hom.:
12410
Cov.:
31
AF XY:
0.380
AC XY:
28181
AN XY:
74128
show subpopulations
African (AFR)
AF:
0.182
AC:
7519
AN:
41408
American (AMR)
AF:
0.346
AC:
5260
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.499
AC:
1728
AN:
3466
East Asian (EAS)
AF:
0.210
AC:
1076
AN:
5132
South Asian (SAS)
AF:
0.481
AC:
2314
AN:
4812
European-Finnish (FIN)
AF:
0.516
AC:
5437
AN:
10532
Middle Eastern (MID)
AF:
0.373
AC:
109
AN:
292
European-Non Finnish (NFE)
AF:
0.483
AC:
32779
AN:
67864
Other (OTH)
AF:
0.383
AC:
804
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1719
3438
5158
6877
8596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.446
Hom.:
7865
Bravo
AF:
0.355
Asia WGS
AF:
0.346
AC:
1208
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.3
DANN
Benign
0.47
PhyloP100
-0.095
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17513926; hg19: chr7-146243404; API